Characterization of two Austrian porcine reproductive and respiratory syndrome virus (PRRSV) field isolates reveals relationship to East Asian strains by Leonie J. Sinn et al.
Sinn et al. Vet Res  (2016) 47:17 
DOI 10.1186/s13567-015-0293-x
RESEARCH ARTICLE
Characterization of two Austrian porcine 
reproductive and respiratory syndrome virus 
(PRRSV) field isolates reveals relationship to East 
Asian strains
Leonie J. Sinn1*, Leonie Zieglowski1, Hanna Koinig2, Benjamin Lamp1, Bettina Jansko3, Georg Mößlacher3, 
Christiane Riedel1, Isabel Hennig‑Pauka2 and Till Rümenapf1*
Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) causes major problems for the swine industry world‑
wide. Due to Austria’s central location in Europe, a large number of animals are transported through the coun‑
try. However, little is known about current PRRSV strains and epidemiology. We determined full‑length genome 
sequences of two Austrian field isolates (AUT13‑883 and AUT14‑440) from recent PRRSV outbreaks and of a related 
German isolate (GER09‑613). Phylogenetic analysis revealed that the strains belong to European genotype 1 subtype 
1 and form a cluster together with a South Korean strain. Remarkably, AUT14‑440 infected the simian cell line MARC‑
145 without prior adaptation. In addition, this isolate showed exceptional deletions in nonstructural protein 2, in the 
overlapping region of glycoprotein 3 and 4 and in the 3′ untranslated region. Both Austrian isolates caused similar 
lung lesions but only pigs infected with AUT14‑440 developed clear clinical signs of infection. Taken together, the 
genetic and biological characterization of two novel Austrian PRRSV field isolates revealed similarities to East Asian 
strains. This stresses the necessity for a more detailed analysis of current PRRSV strains in Europe beyond the determi‑
nation of short ORF5 and ORF7 sequences.
© 2016 Sinn et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Porcine reproductive and respiratory syndrome virus 
(PRRSV) is one of the most economically important 
pathogens in the swine industry worldwide [1, 2]. It is the 
etiological agent of porcine reproductive and respiratory 
syndrome (PRRS), which is characterized by respiratory 
disorders as well as by growth retardation in growing pigs 
and reproductive failure in late gestation sows [3, 4]. The 
disease emerged in the late eighties in North America, 
with the first outbreaks in Europe recorded in 1990 [3].
The causative agent, PRRSV, was first isolated in 1991 
in the Netherlands [4]. This strain, Lelystad virus (LV), 
is regarded as the prototype strain of European PRRSV 
type 1 (PRRSV-1), whereas VR2332 represents the North 
American PRRSV type 2 (PRRSV-2). The two genotypes 
share only about 60% identity at the nucleotide level [5]. 
Due to high mutation and recombination rates [6], vari-
ability is also high within the genotypes, especially in 
type 1. Therefore, three subtypes have been proposed for 
PRRSV-1 based the size of the nucleocapsid protein (N): 
pan-European subtype 1 and Eastern European subtypes 
2 and 3 [7].
PRRSV is a small, enveloped virus with a single-
stranded positive-sense RNA genome that belongs to the 
family Arteriviridae, order Nidovirales [8]. The 5′-capped 
and 3′-polyadenylated genome of PRRSV is about 15 kb 
in length and contains ten open reading frames (ORF) 
[9, 10]. ORF1a and 1b constitute over 75% of the viral 
genome and encode two polyproteins, which are cleaved 
into at least 14 nonstructural proteins (nsp) that are 
responsible for genome replication and transcription 
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[11]. ORF2–4 encode the minor structural proteins, 
including glycoprotein (GP) 2, 3 and 4, which form a 
hetero-trimer that is believed to be involved in virus 
entry [12]. The major structural proteins GP5, membrane 
protein (M) and N protein are encoded by ORF5–7. 
Nucleotide sequences of ORF5 (603–606 bp) and ORF7 
(372–387  bp) are widely used for phylogenetic studies. 
However, the analysis is limited as these short genomic 
sequences might be subject to recombination and immu-
nological selection pressure [6]. Phylogenetic analysis 
based on ORF5 and ORF7 may also lead to different sub-
typing of PRRSV-1 strains [13]. For these reasons, the use 
of further methodologies for genetic subtyping has been 
suggested, such as whole genome sequencing [6, 14]. The 
lack of published full-length sequences is exemplified by 
the situation in Austria, where the limited data on current 
strains consists solely of ORF5 or ORF7 sequences [15–
17]. This gap in knowledge complicates the identification 
of the source of outbreaks, which is crucial as the most 
important PRRSV problems in Austria occur as a con-
sequence of (re-) introduction into formerly free herds. 
An awareness of recent isolates and genomic changes 
that possibly lead to lower protection is also important in 
terms of assessing the effectiveness of vaccines.
The aim of this study was to determine the etiological 
agents of two PRRSV-1 outbreaks in Austria and to char-
acterize them genetically and biologically. The results 
reveal that the isolated PRRSV-1 subtype 1 field strains 
(AUT13-883 and AUT14-440) have genetic and phyloge-
netic similarities to East Asian strains.
Materials and methods
Viruses and cells
Wild-type PRRSV strains AUT13-883 and AUT14-440 
were isolated from sera of two farms in Upper Austria 
in 2013 and 2014. A cell culture adapted PRRSV-1 sub-
type 1 strain (GER09-613) that was isolated from the field 
in Germany in 2009 was also included in the analysis 
(kindly provided by L. Haas, TiHo Hannover). MARC-
145 cells (CCLV RIE 277 [18]) were obtained from the 
Friedrich-Loeffler-Institute in Germany. Preparation of 
porcine alveolar macrophages (PAM) was essentially per-
formed as described previously [19]. Briefly, lungs of 6- to 
12 week-old PRRSV-free, healthy pigs were washed 2–3 
times with PBS (pH 7.2). Aliquots of lavage fluid were 
pooled and centrifuged for 5 min at 1000 g. The cells were 
washed in PBS and repelleted twice. For storage, PAM 
were resuspended in FCS supplemented with 10% dime-
thyl sulfoxide and frozen at −150  °C. MARC-145 cells 
were cultured in Dulbeccos’s modified Eagle’s medium 
(Life Technologies, Waltham, USA) supplemented with 
10% fetal calf serum (Bio&Sell, Nürnberg, Germany) 
and antibiotics (100  U/mL penicillin and 100  µg/mL 
streptomycin). Two additional antibiotics (enrofloxacin 
and kanamycin) were added for the culture of PAM. All 
cells were maintained at 37 °C and 5% CO2 and observed 
daily for cytopathic effects.
Sample collection
Serum samples were collected from two medium-sized 
piglet producers in Upper Austria in November 2013 
(farm 883) and March 2014 (farm 440). Both farms 
were experiencing PRRSV-related problems such as 
pneumonia, wasting, variance in growth, conjunctivitis 
and coughing in rearing piglets, as well as reproduc-
tive disorders such as mummification and abortions in 
sows. Whereas one farm (883) had experienced minor 
problems related to PRRSV over a period of 2  years, 
the other (440) was formerly free of PRRSV and had 
losses of up to 50% in one farrowing badge. Serum 
samples from both farms had been tested positive for 
PRRSV by qRT-PCR by the Animal Health Service 
Upper Austria. Neither of the farms had used vaccines 
against PRRSV.
Virus isolation and titration
For virus isolation, 50 µL serum of diseased piglets from 
farms 440 and 883 were used to inoculate 5 × 106 PAM 
on a six-well format. After 2 days, the cell culture super-
natant was clarified by centrifugation (5 min, 3000 g) and 
passaged on PAM and MARC-145 cells. Virus infection 
was generally analysed 2 days post-infection by immuno-
fluorescence staining. Virus titres of supernatants were 
confirmed on PAM from a single animal to ensure com-
parability and expressed as tissue culture infectious dose 
of 50% (TCID50). In the animal trial a viral stock from the 
6th to 8th passage was used for inoculation.
Detection of PRRSV‑positive cells
Cells were fixed with 1:2 methanol-acetone for 2 min at 
room temperature and air-dried. Anti-PRRSV-N-protein 
monoclonal antibodies (clone P10/b1) [20] (kindly pro-
vided by A. Saalmüller, Vienna) were employed for the 
detection of infected cells. Goat anti-mouse conjugated 
with Cy3 (Dianova/Jackson, Hamburg, Germany) was 
used as a secondary antibody.
Determination and analysis of full‑length genome 
sequences
Total RNA was extracted from PAM 5 days after inocula-
tion and from serum samples using the RNeasy Mini Kit 
and the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. 
RNA was eluted in 30 µL distilled water and either used 
immediately for RT-PCR or stored at −80  °C for subse-
quent analysis.
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RT-PCR was carried out using the LongAmpKit 
(NEB, Ipswich, USA) or the One Step RT-PCR Kit (Qia-
gen, Hilden, Germany) according to the manufacturer’s 
instructions. Seven primer pairs that were highly con-
served in PRRSV-1 strains were designed (available upon 
request) based on published sequences available in NCBI 
GenBank. The resulting PCR amplicons were overlapping 
and covered the whole genome.
The DNA fragments were subjected to gel electro-
phoresis, purified by the peqGOLD Gel Extraction Kit 
(Peqlab, Erlangen, Germany) and sequenced by com-
mercial laboratories (Microsynth Austria, Vienna, Aus-
tria and Eurofins Genomics, Ebersberg, Germany). 
Primer selection for sequencing was based on available 
PRRSV-1 sequences. The determined full-length genome 
sequences of GER09-613, AUT14-440 and AUT13-883 
were submitted to GenBank (KT344816, KT334375 and 
KT326148).
Initial phylogenetic analysis was carried out with 
NCBI’s Basic Local Alignment Search Tool for nucle-
otides (BLASTn). The two closest neighbours of the 
isolates presented in this study were determined for 
ORF5 and ORF7. Pairwise comparison and identity 
calculations were carried out with CLC Main Work-
bench 7.6 (CLCBIO, Aarhus, Denmark). Alignments 
and phylogenetic trees were generated with the soft-
ware CLC Sequence Viewer 7.6 (CLCBIO, Aarhus, 
Denmark) with bootstrap values based on 1000 repli-
cates. All PRRSV-1 strains with full genome sequences 
deposited in GenBank were used to construct the 
phylogenetic trees. For the trees based on ORF5 and 
ORF7, the two closest neighbours—as determined by 
NCBI BLASTn—were added. The PRRSV-2 prototype 
VR-2332 was used as an out-group. Recombination 
analysis was performed with the recombination analy-




Twenty-seven-week-old conventional pigs (#1–20) were 
obtained from a PRRSV-negative herd and housed in 
a biosafety level 2 facility. They had been vaccinated 
against PCV-2 and M. hyopneumoniae in their third 
week of life. To confirm their PRRSV status nasal swabs 
taken at the time of arrival were analysed by qRT-PCR 
and serum samples were tested for antibodies against 
PRRSV with the commercial IDEXX X3 ELISA (IDEXX 
laboratories, Westbrook, USA). The animal experi-
ments were approved by the ethics committee of the 
University of Veterinary Medicine, Vienna and the 
Federal Ministry of Science, Research and Economy 
(BMWF-68.205/0196-WF/V/3b/2014).
Serum titration
Tenfold dilution series of sera were prepared and trans-
ferred to naïve PAM. For each time point and each ani-
mal, two replicates were performed. Three days later cells 
were fixed and stained and the TCID50 was calculated.
Quantitative reverse transcription‑PCR (qRT‑PCR)
To detect viremia, viral RNA was extracted from 140 µL 
serum with QIAamp Viral RNA Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. 
RNA was eluted in 60  µL distilled water and 1  µL was 
directly used for amplification with the KAPA™ SYBR® 
FAST One-Step qRT-PCR Kit (Peqlab, Erlangen, Ger-
many) on an ABI 7500 cycler (Applied Biosystems, Foster 
City, USA). Published primers Pesch PLS (5′-ATGGCC 
AGCCAGTCAATC-3′) and Pesch PLR (5′-TCGCCCT 
AATTGAATAGGTG-3′) were used for amplifica-
tion [22]. A recombinant cDNA clone of a PRRSV-1 
strain was purified using the QIAGEN Plasmid Midi 
Kit (Qiagen, Hilden, Germany) and spectrophotometri-
cally quantified. The copy number of recombinant plas-
mids was calculated with the formula: N (molecules per 
µL) = [C (DNA concentration in µg/µL)/K (fragment size 
in bp)] × 185.5 × 1013 (factors derived from DNA weight, 
volume and the Avogadro constant). To obtain a standard 
curve, a tenfold dilution series of cDNA of the PRRSV-1 
clone was included in the qRT-PCR setup. Cycling condi-
tions were 42  °C 5:00, 95  °C 5:00 and 42 cycles of 95  °C 
0:03, 60  °C 1:00 and 80  °C 0:33 (fluorescence detection 
step) followed by a dissociation step (95  °C 0:15, 60  °C 
1:00, 95  °C 0:15). The numbers of genome copies were 
calculated with the 7500 System SDS Software (Applied 
Biosystems, Foster City, USA) based on the standard 
curve and projected to 1 mL serum by multiplication by 
428.4.
To detect viral shedding, nasal swabs were submerged 
in 2  mL of sterile saline (0.7% NaCl) and thoroughly 
shaken for 30 s. 200 µL of supernatant were used for viral 
RNA extraction with the High Pure Viral RNA Kit (Roche 
Diagnostics, Vienna, Austria) according to the manufac-
turer’s instructions. RNA was eluted in 50 µL of the kit’s 
elution buffer and 13.6 µL were directly used for ampli-
fication with the LightCycler® RNA Amplification Kit 
SYBR Green I with a LightCycler® 480-II System (Roche 
Diagnostics, Vienna, Austria). The nested RT-PCR from 
Pesch [21] was adapted for detection with SYBR Green 
I®. Reverse transcription and activation was performed 
according to the manufacturer’s instructions, followed by 
32 cycles of 60  °C 0:10, 72  °C 0:22 and 95  °C 0:10. The 
nested amplification step was carried out with LightCy-
cler® FastStart DNA Master(plus) SYBR Green I (Roche 
Diagnostics, Vienna, Austria) using 2 µL of the first PCR 
reaction. Cycling conditions were 25 cycles of 60 °C 0:10, 
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72 °C 0:20 and 95 °C 0:20. The fluorescence detection step 
was carried out at 84 °C. The PCR was followed by a dis-
sociation step. Results were considered positive when a 
clear amplification curve was observed and the melting 
temperature of the amplicons (calculated by LightCycler® 
480 System Software) was within the expected range.
Serology
Serum samples were tested for antibodies against PRRSV 
with the commercial IDEXX X3 ELISA (IDEXX labora-
tories, Westbrook, USA) according to the manufacturer’s 
instructions. Ratios of optical densities of sample and 
positive control (P/PK ratios) were calculated and con-
sidered positive when >0.4.
Statistical analysis
Data were analysed with the SPSS statistics software 
(SPSS Ltd, Quarry Bay, Hong Kong). Oneway ANOVA 
with Posthoc LSD test was applied for the analysis of all 
results except for those from the ELISA, which were ana-
lysed with the t test with the test value 0. A p value < 0.05 
was considered statistically significant.
Results
Virus isolation
Two PRRSV-1 outbreaks in 2013 (farm 883) and 2014 
(farm 440) were brought to our attention by the responsi-
ble veterinarians. Case 883 was characterized by mild res-
piratory disorders and a low virus load that persisted over 
2  years. In case 440, suckling piglet mortality reached 
50%, which is severe for PRRSV outbreaks in Austria, and 
abortions were observed. Both farms had been found to 
be PRRSV-1 positive by qRT-PCR before we obtained any 
samples. To investigate the PRRSV strains responsible for 
the outbreaks, we isolated two viruses from the serum of 
diseased piglets after serial inoculation of PAM (termed 
AUT13-883 and AUT14-440). MARC-145 cells were also 
susceptible for AUT14-440 without adaption but were 
not infected by AUT13-883.
Phylogenetic analysis
The sequences of the ORF5 and 7 genes revealed that 
both isolates belong to PRRSV-1 subtype 1 [7] but the 
results for ORF5 and ORF7 were not consistent. In the 
phylogenetic tree based on ORF5, AUT14-440 clustered 
together with German and South Korean PRRSV-1 iso-
lates (among them KNU-07) (Additional file 1). AUT13-
883 represented a different branch of the tree and was 
most closely related to German strain EU-2a from 1992 
[23] and to Austrian strain 2888 [15]. In contrast, when 
ORF7 sequences were used for phylogenetic analysis, 
the two Austrian isolates formed a group together with 
Korean strain KNU-07 [24], a Croatian strain [25] and 
German strains [26] (Additional file 2).
Since the results of the phylogenetic trees based on 
ORF5 and ORF7 were inconclusive, complete genome 
sequences for AUT13-883 and AUT14-440 were deter-
mined (GenBank: KT326148 and KT334375). A phylo-
genetic tree based on the full genome sequences of the 
isolates presented in this study, 38 published PRRSV-1 
strains and PRRSV-2 prototype VR-2332 (Figure  1) 
confirmed the relationship between the two Austrian 
isolates, GER09-613 and KNU-07. All four strains clus-
ter together, with no other strain in the same branch. 
AUT13-883 and GER09-613 are the most closely related 
strains.
Distinct deletions in the genome of AUT14‑440
Assembly of the overlapping sequences resulted in com-
plete genomes consisting of 15022 nucleotides (nt) for 
AUT14-440 and 15095 nt for GER09-613 and AUT13-
883, excluding the 3′ poly(A) tails. Detailed comparison 
to the European prototype LV revealed marked differ-
ences in the region of nsp2. Both Austrian virus isolates 
and the German strain GER09-613 possess a shorter 
ORF1a due to deletions in nsp2 (Figure  2). The differ-
ence of three nucleotides in ORF1a between AUT13-883 
(7188 nt) and LV (7191 nt) results in the deletion of pro-
line 182 in nsp2 (Figure 3A, dotted line box). The deletion 
is also present in the South Korean strain KNU-07 and 
has been described for strains from Hong Kong. GER09-
613 and AUT14-440 (ORF1a lengths of 7188 and 7152 
nt) share a deletion of three nt, resulting in the loss of 
glutamine 183 in nsp2, one amino acid (aa) downstream 
of proline 182 (Figure 3A, dotted line box). In compari-
son to LV, AUT14-440 has further deletions in nsp2 at 
aa positions 320–323, aa 359–364 and aa 699–700, all 
in hypervariable regions of nsp2 where deletions are 
frequently found (Figure  3A, solid line boxes). ORF3 
and ORF4 of AUT14-440 were also truncated by 36 nt 
when compared to LV, resulting in a deletion of 12 aa in 
the overlapping region of GP3 and GP4 (Figures 3B and 
C solid line boxes). Shorter deletions (up to 8 aa) in this 
area have been described for several strains, including 
HK5 and the Chinese isolate BJEU06-1. AUT14-440 also 
shows a single nucleotide deletion at position 87 in the 
3′ untranslated region (UTR) (Figure 3D, solid line box). 
All deletions in virus isolate AUT14-440 were also found 
when RNA from the original serum sample was used for 
RT-PCR and PCR products were directly sequenced. 
Pairwise nucleotide comparison of the complete 
genome resulted in identities of 87.7, 87.9 and 88.6% 
with LV for AUT14-440, AUT13-883 and GER09-613. 
Identities between the isolates were 86.4% (GER09-613 
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to AUT14-440), 85.4% (AUT14-440 to AUT13-883) and 
89.9% (AUT13-883 to GER09-613) (Figure 2).
Determination of virulence
Genetic and phylogenetic analysis showed a striking 
relationship between the Austrian isolates, the German 
strain GER09-613 and the South Korean strain KNU-07. 
The reported severity of the clinical symptoms associ-
ated with AUT13-883 and AUT14-440 differed markedly, 
while the clinical symptoms of GER09-613 have not 
been described. However, the particular clinical signs 
in an affected herd provide no more than an indication 
of the pathogenicity of a PRRSV isolate, as other patho-
gens may be involved. To assess the virulence and to test 
Koch’s postulates, an animal trial was performed with the 
Austrian isolates AUT13-883 and AUT14-440 and the 
German isolate GER09-613, which clusters in the same 
branch of the phylogenetic tree.
PRRSV-seronegative pigs were distributed equally 
into four groups according to their weight and sex. Each 
Figure 1 Phylogenetic analysis based on nucleotide sequences of full-length genomes of 41 PRRSV-1 strains and PRRSV-2 prototype 
VR2332 as an out-group. The PRRSV strains presented in this study are marked in red and the associated sub‑tree is highlighted with a box. The 
tree was constructed using the neighbour joining method with the numbers at the nodes representing bootstrap values in % of 1000 replicates. 
Scale bar: number of substitutions per site.
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group of five animals was housed in a separate com-
partment to avoid cross-contamination. After 1  week 
of adaptation (day 7 to day 0), pigs from groups GER09-
613, AUT13-883 and AUT14-440 were inoculated 
intranasally with 3  mL medium (1.5  mL in each nos-
tril) containing 1 × 105 TCID50 of the respective strain. 
Pigs from the control group received the same amount 
of medium without virus. Clinical signs and rectal tem-
perature were monitored daily. A scoring system was 
applied that rates liveliness, dyspnoea, coughing, nasal 
and ocular discharge, conjunctivitis and cyanosis with 
scores from 0 (physiological) to 3 (severe clinical signs). 
Daily scores for each animal were added to obtain a 
value for the overall health status and the mean clinical 
scores for the four groups were calculated (Figure  4A). 
All pigs infected with AUT14-440 showed mild to mod-
erate dyspnoea on three or more study days. Other 
clinical signs that occurred frequently in all animals in 
this group were apathy and conjunctivitis. Two waves 
of clinical signs could be distinguished: the first wave 
occurred around day 4 post infection (pi) and the sec-
ond, with more prominent signs of illness, took place 
around day 12 pi. In the other infection groups, only one 
(AUT13-883) or two (GER09-613) animals showed mild 
dyspnoea for no more than 2 days in a row. Pigs in the 
control group showed no relevant clinical signs in the 
trial, except for animal #4 that had to be euthanized on 
study day 10 due to a severe lameness in the hind legs. 
There was no significant difference in rectal temperature 
between the four groups.
The pigs were weighed at −7, 0, 3, 7, 10 and 13  days 
post infection (dpi). For each week of the trial (study 
days −7 to 0, 0 to 7, 7 to 13) daily weight gain was cal-
culated and is shown for each group as a box plot with 
maximum and minimum values represented as whiskers 
(Figure  4B). From the first week to the second week of 
the trial, all groups showed an average increase of daily 
weight gain between 0.08 and 0.16 kg. From the second to 
the third week, the control group and group GER09-613 
showed a mean increase of daily weight gain of 0.05 and 
0.11 kg, whereas in the groups infected with the Austrian 
field isolates daily weight gain did not increase (mean 
values of −0.07  kg for AUT14-440 and −0.02  kg for 
AUT13-883). Despite the apparent differences between 
the groups, the figures are not statistically significant due 
to the small group size and the high variation within the 
Figure 2 Detailed comparison of complete genomes of GER09-613, AUT14-440, AUT13-883 and Lelystad virus (LV) (table) and 
schematic overview of nucleotide differences between LV and the isolates presented in this study. Black bars represent areas with a 
low degree of similarity to LV. Open reading frames (ORF) of PRRSV that encode non‑structural proteins (blue) and structural proteins (orange) are 
shown.
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Figure 3 Multiple alignments of partial nsp2 (A), GP3 (B) and GP4 (C) amino-acid sequences of eleven different European PRRSV strains. 
Only aa differing from Lelystad virus (LV) are shown, with identical aa represented by dots. Deletions compared to LV are marked in red. Deletions of 
AUT14‑440 are highlighted with solid boxes; a deletion in all three isolates is indicated with a dotted box. The numbers above the alignment indicate 
the position in the protein. A A single aa deletion is present in all three isolates and KNU‑07 at position 182 or 183 in nsp2. In AUT14‑440 aa 320–323, aa 
359–364 and aa 699–700 are deleted compared to LV. B, C The box marks a 12 aa deletion in the overlapping region of GP3 and GP4 of AUT14‑440. D 
Multiple alignment of 3′‑UTR nucleotide sequences of ten European PRRSV strains. Nucleotides differing from Lelystad virus (LV) are shown, with identical 
nucleotides represented by dots. A deletion of 1 nt at position 87 in AUT14‑440 is marked in red and highlighted with a solid box.
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groups (p = 0.055 between GER09-613 and AUT14-440 
for the third week).
Gross pathology and histopathology
At 13 and 14 dpi, pigs were euthanized and necropsied 
with special emphasis on the lungs. No other organs than 
lungs showed pathological lesions. Samples from each 
lung lobe were fixed in formalin, embedded in paraffin, 
stained with hematoxylin and eosin and examined his-
tologically. Lesions were hypertrophy and hyperplasia of 
pneumocytes, septal infiltration by mononuclear cells, 
perivascular and intraalveolar accumulation of inflam-
matory cells and necrotic debris. Depending on their 
occurrence in different lung lobes and on the severity of 
the lesions, a total score per lung was calculated, applying 
a PRRSV specific scoring system that has been described 
elsewhere [27]. The mean values for the Austrian iso-
lates were 52.4 ± 20.9 for AUT14-440 and 53.6 ± 9.4 for 
AUT13-883 (Figure 5A). In these two groups all types of 
lesions mentioned above were present in mild to severe 
manifestations with no visible differences between the 
groups. The results differed significantly (p < 0.01) from 
both the control group with a mean score of 5.6 ± 3.0 and 
group GER09-613, which mainly showed minor accumu-
lations of inflammatory cells (mean histological score of 
B 
A
1st  2nd 3rd  1st  2nd 3rd  1st  2nd 3rd  1st  2nd 3rd
Figure 4 Clinical signs and daily weight gain. A Pigs were examined daily and a clinical score was calculated based on the severity of PRRSV‑
associated clinical signs. The mean values for each group are shown with a continuous line and single spots represent individual animals. As group 
AUT14‑440 was euthanized on day 14 pi there are values for 1 day more than for the other groups. B Pigs were weighed at six time points and 
daily weight gain was calculated for three time frames: 1st week (−7 to 0 dpi), 2nd week (0 to 7 dpi) and 3rd week (7 to 13 dpi) of the trial. Whiskers 
represent maximum and minimum values. Differences between the groups were visible for the last time period, 7–13 dpi, although they are not 
statistically significant (p = 0.055 between GER09‑613 and AUT14‑440).
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15 ±  6.0). The scores for each group are displayed as a 
boxplot in Figure 5B.
Viremia and virus shedding
To exclude the possibility of cross-contamination 
between the groups, 50  µL of serum taken 3 dpi from 
one animal per group (#10, 14, 19) were inoculated onto 
naïve PAM and virus was re-isolated. RT-PCR and subse-
quent sequencing of the 700 bp PCR amplicon covering 
ORF4 confirmed the identity of the viral strains. Com-
pared to the parental strain, two point mutations were 
detected in each strain. One of them was the same for all 
three strains and resulted in an amino-acid change from 
aspartic acid to asparagine at position 33 in GP4. In addi-
tion melting temperatures of amplicons from positive 
nasal swabs confirmed that no cross-contamination had 
occurred (data not shown).
Viral nucleic acids in serum could be detected with 
qRT-PCR as early as day 3 pi in all animals from group 
AUT14-440 and in two animals from group AUT13-
883 (Figure 6). In the GER09-613 group, the first virus-
positive animals were detected 10 dpi. On day 13 pi all 
animals from this group except one (#8) tested positive 
for viral RNA; animal #8 remained negative for qRT-
PCR as well as for titration on PAM (data not shown) 
on all sampling days. The number of genomic copies in 
the serum of animals infected with AUT14-440 declined 
towards the end of the trial. In the AUT13-883 group, 
the onset of viremia differed between the pigs. The max-
imum number of genome copies per mL serum was up 
to 100 times higher in the AUT14-440 group than in the 
other groups. On days 3 and 7 pi, the difference between 
group AUT14-440 and all other groups was significant 
(p < 0.01), whereas on day 10 pi only the difference to the 
control group and the AUT13-883 group was significant 
(p < 0.05). Serum titres on PAM were also highest in the 
AUT14-440 group (up to 2.3 × 103 TCID50/mL, data not 
shown). Viral RNA or infectious virus could be detected 
in the serum of all infected animals, except for #8, with 
qRT-PCR and titration on PAM on one or more sampling 
days. The animals from the control group gave negative 
results with both assays throughout the trial.
To examine virus shedding from the upper respiratory 
tract, nasal swabs were taken at −7, 3, 7, 10 and 13 dpi 
and analysed with qRT-PCR for PRRSV-specific nucleic 
acids (data not shown). All animals from infected groups 
were virus-positive 3 dpi. Group GER09-613 tested com-
pletely negative on day 7 pi and one pig (#8) remained 
negative until the end of the trial, while the other animals 
tested positive on day 10 and 13 pi. Virus shedding could 
be determined for four pigs each from groups AUT14-
440 and AUT13-883 on study days 7 and 10, whereas 
only two animals from group AUT14-440 and all ani-
mals from group AUT13-883 were positive on the last 
Figure 5 Histological lung lesions. For each animal, a histopathological lung lesion score was calculated by considering the degree of PRRSV‑
associated lesions in every lung lobe. Histological lesion scores are presented A in a table and B as a box‑plot. Mean score (±standard deviation) 
and individual scores for each animal are displayed for all groups. B Whiskers represent maximum and minimum values. Letters indicate significant 
differences (p < 0.01) from control group (a), group GER09‑613 (b), group AUT14‑440 (c) and group AUT13‑883 (d).
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sampling day, day 13. The nasal swabs from the control 
group tested negative for PRRSV-specific nucleic acids at 
every time point.
Serology
Antibody titres against PRRSV were determined at the 
beginning of the trial to ensure the PRRSV-free status of 
the animals. At this time point all pigs tested negative for 
N-specific antibodies with the commercial IDEXX X3 
ELISA (Figure  7). Pigs were further screened for sero-
conversion 7, 10 and 13 dpi. First detection of PRRSV-
specific antibodies was possible 7 dpi in the sera of two 
pigs from groups AUT14-440 and GER09-613. On days 
10 and 13 pi all infected animals but one (#19) tested pos-
itive in ELISA. The clearest antibody response with the 
highest P/PK ratios was seen in the AUT14-440 group. 
The animals from the control group were negative for 
PRRSV-specific antibodies at every time point.
Discussion
Austria is surrounded by seven neighbouring countries 
and lies on the border between Western and Eastern 
Europe. Due to its central location it has become a major 
European corridor for travel and the movement of goods, 
including live pigs. In fact, one of the isolates (AUT440-
14) originated from a farm directly adjacent to the major 
west-east transit road. The reintroduction of PRRSV into 
virus-free herds is the most urgent yet least understood 
problem for the swine industry in Austria. Epidemiologi-
cal evidence is often insufficient as only few ORF5 and 
ORF7 sequences from Austria are accessible at GenBank, 
most of them originating from only three publications 
[15–17]. In none of these cases were sequence data cor-
related to the biological properties of the isolates.
In this study, the initial question about the phyloge-
netic background of two field strains not only led to 
complete genome sequences of two recent Austrian 
field isolates but also to their characterization in  vivo. 
(Phylo-) genetic information could be interpreted in the 
light of the phenotypic properties of the isolates. This is 
especially important because genetic relationships do 
not give evidence for the virulence of PRRSV strains [6]. 
To go beyond the descriptive determination of selected 
sequences, it is necessary to address the pathogen’s prop-
erties by carefully characterizing the isolate.
The initial virus isolation in this study was performed 
on primary PAM, which are believed to be the main 
target cells of PRRSV in  vivo and are widely used for 
PRRSV-1 isolation and propagation [28]. The much more 
convenient simian cell line MARC-145 can usually not be 
used for unadapted PRRSV-1 virus strains, although it is 
readily infected by PRRSV-2 without adaptation [6, 28]. 
Interestingly, it also supported growth of the first passage 
Figure 6 Viral load in serum quantified by qRT-PCR. For each infected group qRT‑PCR results are displayed as genome copies per mL serum 
for −7, 3, 7, 10 and 13 dpi. Whiskers represent maximum and minimum values. Letters indicate significant differences (p < 0.05) to group GER09‑613 
(a), AUT14‑440 (b) and AUT13‑883 (c).
-7  7 10  13  -7 7  10 13 -7  7 10 13 
Figure 7 Antibody response to PRRSV infection. ELISA IDEXX 
X3 results as a ratio of the optical density (OD) of the sample and the 
OD of the positive control for infected groups at −7, 7, 10 and 13 dpi. 
Values over the cut‑off at 0.4 (dotted line) were regarded as positive. 
Whiskers represent maximum and minimum values.
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of AUT14-440, a PRRSV-1 isolate. This observation 
encouraged us to investigate the phylogenetic classifica-
tion of the strain.
Virus isolation is rarely performed in routine PRRSV 
diagnostics and sequences are normally obtained directly 
from clinical samples. Generally, only ORF5 or ORF7 
sequences are determined. However, there are doubts 
about the validity of phylogenetic trees based solely on 
ORF5 or ORF7 sequences because of the recombination 
potential and high rate of nucleotide substitution shown 
by these genes [6, 14]. As a matter of fact, in the phyloge-
netic trees we determined based on ORF5 and 7 the rela-
tionship between the two Austrian isolates and closely 
related strains remained unclear as AUT13-883 grouped 
differently in the two trees. The difference might relate 
to recombination events, which are believed to have a 
major impact on PRRSV diversity [6, 29]. No evidence 
for this phenomenon was found by recombination anal-
ysis, probably due to the small number of full PRRSV-1 
genomes available in GenBank (data not shown). This 
finding underlines the need for more full-length genome 
sequencing. The phylogenetic tree based on full genomes 
clearly showed relatedness between the two Austrian 
isolates, the German strain GER09-613 and the South 
Korean isolate KNU-07. However, it has to be considered 
that the four strains cluster together in a phylogenetic 
tree despite not being closely related (identities between 
85.4 and 90.2%) and that only 38 PRRSV-1 strains were 
available for comparison, most of them from earlier than 
2010. The picture might be less clear if the full genome 
sequences of more (recent) strains were available for 
inclusion in the analysis. At present we can only specu-
late whether the South Korean strain was imported to 
Europe or whether the cluster is the result of convergent 
evolution. It is also possible that all four strains originate 
from older strains from Germany (e.g., BH_95_10-08_
EU) that show close relationships in ORF5 and ORF7 but 
for which complete sequences are not available. Detailed 
epidemiological statements will not be possible without a 
broader range of full-length PRRSV genomes.
Nevertheless, comparing not only a small part of 
the 15  kb PRRSV genome but full sequences revealed 
remarkable characteristics of the strains and provided 
indications that the four strains have a common origin. 
AUT13-883 and KNU-07 have a proline deletion in nsp2 
that has only been noted in several strains from Hong 
Kong [30]. AUT14-440 and GER09-613 also share a sin-
gle aa deletion in nsp2, a single position after the proline. 
Additionally, on either side of the 12 aa deletion in GP3 in 
AUT14-440 the four strains share areas of aa sequences 
that are very similar to one another but clearly differ 
from those of other PRRSV-1 strains, providing further 
indications of a possible relationship.
A closer look at the full genome sequences revealed 
additional deletions in strain AUT14-440. In nsp2, three 
more deletions of 2–6 aa support the conclusion from 
the phylogenetic analysis that the isolate is not as closely 
related as the three other strains. The 12 aa deletion in 
the overlapping region of GP3 and GP4 is unique to this 
strain. Other published isolates that carry a deletion in 
this highly variable area only miss 1–8 aa compared to 
LV and the concomitant occurrence of deletions in nsp2 
and ORF3/4 has only been described for a few Chinese 
strains [31–33]. The first strains carrying a deletion in the 
overlapping region of ORF3 and ORF4 were isolated in 
Denmark as long ago as 1992, shortly after the discovery 
of PRRSV. In subsequent evaluations, deletion mutants 
were reported to evolve more quickly than non-deleted 
viruses [34]. This might be due to immunological pres-
sure, since neutralizing antibodies against this region in 
GP4 have been described in  vitro for LV [35] and two 
Belgian strains [36]. This region and the corresponding 
region in GP3 were also shown to be immunogenic for 
other isolates, including a Danish deletion mutant with 
an 8 aa deletion [34, 37]. Therefore, it is very likely that 
the highly variable region in the overlap of GP3 and GP4 
is under negative selection pressure, causing deletions or 
mutations to occur [38]. This is in line with the existence 
of very similar aa sequences next to the deletion in the 
Austrian isolates and their nearest relatives GER09-613 
and KNU-07, indicating that the four strains evolved in 
a similar direction, probably due to immunological pres-
sure. The 12 aa deletion in AUT14-440 might prevent the 
binding of GP4-specific antibodies and thereby result in 
an evolutionary advantage. This idea will be tested in fur-
ther experiments.
Another interesting aspect of the deletion is the fact 
that the heterotrimeric minor glycoproteins GP2, GP3 
and GP4 are abundant on the viral surface and probably 
determine cell tropism [39]. A deletion of 12 aa in two of 
these proteins might lead to an altered cell tropism, as 
seen in this study for AUT14-440, which is, despite its 
type 1 genotype, capable of infecting MARC-145 cells. 
The single nt deletion in the 3′UTR of AUT14-440 has 
not been described in other PRRSV-1 strains, although 
there is a report of a deletion at a different position 
within the 3′UTR in highly pathogenic Chinese strains 
[40]. As the 3′UTR is essential for PRRSV replication 
[41], deletions in this area might have an implication for 
the replication efficacy of the virus.
AUT14-440 differed from the other Austrian iso-
late AUT13-883 and the German isolate GER09-613 
also in other aspects. It was the only strain to cause 
clear respiratory distress in pigs in the animal trial. 
Animals infected with AUT14-440 ceased to increase 
daily weight gain in the second week after infection, 
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highlighting the economic relevance of the strain. 
Although pigs from the other groups remained rela-
tively healthy throughout the trial, moderate to severe 
lung lesions were found in pigs infected with AUT13-
883, which also showed varying developments of daily 
weight gain. It is conceivable that clinical signs would 
have been more prominent in all infection groups if a 
less natural route of infection, e.g., intramuscular, or 
higher viral titres had been chosen.
Viremia was already detected 3 dpi in pigs infected with 
the Austrian strains, which is in accordance with other 
experimental infections [42, 43], whereas the GER09-613 
group showed the first viral RNA and titres in serum 10 
dpi. A likely explanation for the late onset and the lack 
of clinical signs is that strain GER09-613 was cell-culture 
adapted on MARC-145 cells and hence potentially atten-
uated and thus had to re-adapt to the host. Future stud-
ies will be necessary to address the sequence differences 
between inoculated GER09-613 and the re-isolated virus.
In the present study, high amounts of viral RNA in 
blood were associated with severity of clinical signs, with 
titres of AUT14-440 exceeding those of the other strains 
by up to 100-fold. In contrast, the amounts of viral RNA 
in nasal swabs were lowest for pigs infected with AUT14-
440, indicating that the amount of virus shedding via 
the respiratory route is not necessarily correlated with 
viremia. The detection of virus shedding 3 dpi is prob-
ably an artefact of intranasal infection, as pigs from group 
GER09-613 do not show any viral RNA in nasal swabs 7 
dpi, which corresponds to the late onset of viremia in this 
group.
The early detection of non-neutralizing N-specific anti-
bodies is in accordance with previous studies [42, 43]. 
The IDEXX X3 ELISA is not quantitative but the high P/
PK ratios of group AUT14-440 are in agreement with the 
high number of viral genome copies in the blood of ani-
mals infected with this strain.
In summary, we have determined the complete genome 
sequence of two recent Austrian field isolates of PRRSV 
and interpret the nucleic acid sequences and the phylog-
eny in the light of the strains’ in vivo characteristics. Both 
isolates cluster with a German field isolate from 2009 and 
the South Korean KNU-07 strain in whole genome phy-
logenetic analysis. One of the field isolates, AUT14-440, 
caused clinical signs in an animal experiment, grew on 
MARC-145 cells and showed exceptional deletions. These 
well characterized isolates represent an excellent basis 
for further studies on the implications of the described 
molecular properties on virus entry, replication and path-
ogenicity. It remains unclear whether the similarities to 
East Asian strains are unique to European strains because 
of the lack of full genome sequences of strains currently 
present in the field. As PRRSV strains are subject to 
constant evolutionary pressure, both from vaccination 
and from instruments of modern herd management, it is 
of the utmost importance to keep up with the increasing 
diversity of PRRSV by studying current isolates.
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